Hemenway Trust Hemenway Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Hemenway Trust Hemenway Trust’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-5,423	Closed	-$356K	–	156
2015 Q4	$356K	Hold	5,423	–	–	0.09%	110
2015 Q3	$306K	Sell	5,423 -1,061	-16%	-$68.8K	0.08%	124
2015 Q2	$383K	Hold	6,484	–	–	0.1%	123
2015 Q1	$404K	Sell	6,484 -533	-8%	-$31K	0.11%	116
2014 Q4	$404K	Buy	7,017 +604	+9%	+$33.7K	0.12%	93
2014 Q3	$345K	Sell	6,413 -350	-5%	-$18.5K	0.11%	103
2014 Q2	$355K	Buy	+6,763	New	+$346K	0.11%	105
2013 Q4	–	Sell	-7,749	Closed	-$293K	–	183
2013 Q3	$293K	Sell	7,749 -61,879	-89%	-$2.41M	0.11%	98
2013 Q2	$2.73M	Buy	+69,628	New	+$2.71M	1.16%	38

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Hemenway Trust Hemenway Trust's TEVA Position: Q1 2016 in Review

Hemenway Trust Hemenway Trust sold out of Teva Pharmaceuticals (TEVA) in Q1 2016, closing a stake of 5,423 shares — an estimated $356K sold.

Hemenway Trust Hemenway Trust first reported a position in TEVA in Q2 2013 and held it in 9 quarters. The position peaked at $2.73M in Q2 2013. 836 funds tracked by Wall St. Rank hold TEVA as of Q1 2016.

Hemenway Trust Hemenway Trust reported no remaining Teva Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
Hemenway Trust Hemenway Trust sold 5,423 Teva Pharmaceuticals shares in Q1 2016, an estimated $356K.
Hemenway Trust Hemenway Trust first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 9 quarters.
Hemenway Trust Hemenway Trust's Teva Pharmaceuticals position peaked at $2.73M in Q2 2013.
836 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2016.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q1 2016, filed 27 May 2016.